Therefore, the significant breakthrough that DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5 may provide a valuable target for molecular therapy of chordoma patients. The gene discussed is DEPDC1B; the disease is chordoma.